Free trial
Subscribe

Log in

Emerging risks | Growth Opportunities | APAC Insurance

Wednesday, July 15, 2026

Dedicated hubs

Insight by…

Insight by type

Cancer
manulife-guardant-health-to-launch-multi-cancer-blood-test-in-asia-in-april
Manulife brings Guardant Health’s Shield MCD cancer screening to Hong Kong, Philippines, and Singapore
March 17 2026
The Shield MCD test screens for 10 of the most common cancers — bladder, colorectal, breast, prostate, esophageal, gastric, liver, lung, ovarian, and pancreatic — with just a blood draw.
aswata-peak-re-launch-cancer-care-programme-for-indonesians
New Aswata-Peak Re product offers Indonesian cancer patients US treatment and travel cover
February 12 2026
The new plan offers Indonesian residents up to US$2m in annual cover and access to leading US cancer centres.
malaysian-re-cpic-and-kunpeng-to-collaborate-on-development-of-health-insurance-products
Malaysian Re partners with CPIC and Kunpeng on health insurance product development
April 19 2024
New MOU aims to develop new products for Malaysian market, with a particular emphasis on cancer treatment.
A nurse is talking to a patient in a hospital bed.
Income Insurance and Swiss Re react to Singapore's rising cancer costs with new insurance product
August 24 2023
'Complete Cancer Care' has been introduced amid rising cancer treatment costs in Singapore, which is set to exceed SG$2bn (US$1.48b) by 2030.
The Inaugural Recognising excellence in Asia's insurance industry Find out more → Entries close
28 August